<DOC>
	<DOC>NCT00743990</DOC>
	<brief_summary>This study seeks to subjectively evaluate whether a single application of Vicks® VapoRub® (VVR) ointment or a control ointment (petrolatum) will be superior to no treatment for control of nocturnal cough and congestion due to upper respiratory tract infection (URI) as rated by both parents and children.</brief_summary>
	<brief_title>Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<mesh_term>Petrolatum</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<mesh_term>Camphor</mesh_term>
	<criteria>Cough and congestion attributed to upper respiratory tract infection Children with signs or symptoms of more serious or treatable disease Presence of itchy, watery eyes or frequent sneezing Tachypnea (respiratory rate &gt;95%ile) or labored breathing Symptoms for 8 or more days History of asthma in the past 2 years, chronic lung disease, or seizure disorder History of an allergic reaction to camphor, menthol, eucalyptus, petrolatum, cedarleaf oil, nutmeg oil, thymol, turpentine oil, Overthecounter medication containing VVR components</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Cough symptoms</keyword>
	<keyword>Cold symptoms</keyword>
	<keyword>Congestion</keyword>
	<keyword>Children</keyword>
	<keyword>URI</keyword>
	<keyword>Alternative cough symptom treatment</keyword>
</DOC>